Medcan Australia’s mission –
“To provide reliable access to patient specific Medicinal Cannabis products”
Founded with a single vision to provide Australian patients with a high quality, fair priced product, Medcan Australia is positioned to be a front runner in the Australia Medicinal Cannabis Industry.
With a vertically integrated model Medcan Australia will Cultivate, Produce and Manufacture high quality medicinal cannabis products for both clinical trials and individual patient access. Our automated cultivation processes are designed to ensure consistent results so consumers are assured the quality, composition and reliability of their supply
Medcan Australia was granted the 13th Cultivation and Production licence from the Office of Drug Control in November 2017 with a nominated commencement start date for production being the 1st of July 2018. Medcan was granted the ODC Medical Cannabis Manufacture Licence.
Medcan Australia believe Medicinal Cannabis is not simply a “one pill suites all” solution. Individual patients have specific needs and requirements and we aim to provide a specific product range based on a patient’s specific set of circumstances.
Medcan Australia currently holds the following Office of Drug Control (ODC), Federal & State licenses making it one of few companies that can Cultivate, Produce and Manufacture Medicinal Cannabis Products:
o ODC Medical Cannabis Cultivation and Production Licence
o ODC Import Licence
o ODC Medical Cannabis Manufacture Licence
o ODC Export Licence
o DAWR (Department of Agriculture and Water Resources) Permit
o QLD Health Licence – Schedule 9 Substances
Medcan Australia’s facility with has the ability to produce up to 6,500kgs of dried cannabis per year.